Leonardo Rivadeneyra

Associate Director, Translational Medicine. at Agios Pharmaceuticals

Leo Rivadeneyra, PhD, currently serves as Associate Director of Translational Medicine at Agios Pharmaceuticals, a position held since January 2022, after progressing through roles including Senior Scientist and Scientist in the same discipline. Prior experience includes a Postdoctoral Fellowship at Versiti Blood Center of Wisconsin from April 2017 to January 2022 and a Postdoctoral Research Fellow position at Academia Nacional de Medicina de Buenos Aires from April 2011 to April 2017, where significant contributions were made in understanding neutrophil interactions with Coxsackievirus B3 and their implications in inflammatory responses. Earlier academic endeavors included specialization in platelet and megakaryocyte biology during the PhD program at the University of Buenos Aires, complemented by a Bachelor's degree in Biotechnology from Universidad Nacional de Quilmes. Additional instructional experience was gained as a Teaching Assistant at Universidad Austral - Argentina and research experiences included work on recombinant baculovirus systems and drug delivery technologies.

Location

Boston, United States

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Agios Pharmaceuticals

5 followers

Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway.


Industries

Employees

201-500

Links